• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, July 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Study reveals large differences in drug prescriptions for newborns between NICUs

Bioengineer by Bioengineer
April 23, 2018
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Little is known concerning how extensively drugs are prescribed to newborns in different neonatal intensive care units (NICUs). A new British Journal of Clinical Pharmacology study of nearly 1,500 newborns admitted during 12 months to four different NICUs in The Netherlands found that drug use varies widely.

Cardiovascular and nervous system drugs were most often prescribed off-label in relation to newborns' age, and their prescription was highly variable between NICUs.

"These differences became larger with decreasing postmenstrual age although the proportion of off-label prescriptions in relation to neonatal age decreased," said lead author Dr. Robert Flint, of Erasmus Medical Center – Sophia Children's Hospital in The Netherlands.

The findings indicate that drug research in newborns should have high priority to ensure the use of safe and appropriate drug therapy in such young patients.

###

Media Contact

Josh Glickman
[email protected]

http://newsroom.wiley.com/

http://dx.doi.org/10.1111/bcp.13563

Share12Tweet7Share2ShareShareShare1

Related Posts

Study Examines Physical Health Differences Across Fall-Risk Groups

July 18, 2026

Avian Influenza Ecological Shifts After HPAIV Arrivals in Southwestern Alaska, 2011–2024

July 18, 2026

Texas Tech Veterinary Students Publish Research in International Journals

July 18, 2026

Journal of Nuclear Medicine Releases Ahead-of-Print Update for July 17, 2026

July 18, 2026
Please login to join discussion

POPULAR NEWS

  • A painless adhesive

    49 shares
    Share 20 Tweet 12
  • Groundbreaking Discovery: New Shark Species Identified for the First Time

    34 shares
    Share 14 Tweet 9
  • 研究人员开发认知工具包,实现阿尔茨海默症早期检测

    50 shares
    Share 20 Tweet 13
  • A varied menu

    51 shares
    Share 22 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

The concealed geometry behind breeding constraints

Study Examines Physical Health Differences Across Fall-Risk Groups

UVA Engineer Geoff Geise Wins NAMS Permeance Prize for Mid-Career Excellence

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.